Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research. The respiratory, enteric, orphan virus (commonly known as reovirus) is a non-attenuated, ...